Dr. Minal Barve, MD
Claim this profileMary Crowley Cancer Research
Area of expertise
Solid Tumors
Minal Barve, MD has run 23 trials for Solid Tumors. Some of their research focus areas include:
Cancer
Minal Barve, MD has run 17 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Mary Crowley Cancer Research
Mary Crowley Cancer Research Center
Clinical Trials Minal Barve, MD is currently running
EU101
for Solid Cancers
Phase 1 (Dose Escalation) of this study will assess the safety, tolerability, dose-limiting toxicity (DLT), and will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of EU101 in participants with advanced solid tumors. Phase 2 (Dose Expansion) of the study will assess the antitumor effect of EU101 in two indications including colorectal cancer (CRC) and non-small cell lung cancer (NSCLC).
Recruiting
1 award
Phase 1 & 2
10 criteria
AdAPT-001
for Cancer
AdAPT-001 is an oncolytic virus that is injected directly into the tumor or via intraarterial administration. The purpose of this study is to find out if AdAPT-001 is safe and tolerable. The next step is to find out if AdAPT-001 if efficacious with or without a checkpoint inhibitor.
Recruiting
1 award
Phase 2
17 criteria
More about Minal Barve, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 46 trials as a Principal Investigator · 13 Active Clinical Trials
Treatments Minal Barve, MD has experience with
- Pembrolizumab
- Niraparib
- Docetaxel
- Retifanlimab
- SV-BR-1-GM
- Gemcitabine
Breakdown of trials Minal Barve, MD has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Minal Barve, MD specialize in?
Minal Barve, MD focuses on Solid Tumors and Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Minal Barve, MD currently recruiting for clinical trials?
Yes, Minal Barve, MD is currently recruiting for 13 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Minal Barve, MD has studied deeply?
Yes, Minal Barve, MD has studied treatments such as Pembrolizumab, Niraparib, Docetaxel.
What is the best way to schedule an appointment with Minal Barve, MD?
Apply for one of the trials that Minal Barve, MD is conducting.
What is the office address of Minal Barve, MD?
The office of Minal Barve, MD is located at: Mary Crowley Cancer Research, Dallas, Texas 75230 United States. This is the address for their practice at the Mary Crowley Cancer Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.